PDF
Citation
Print
INTRODUCTION
Aneurysmal rupture is the most common cause of spontaneous subarachnoid hemorrhage (SAH). Other causes include dissection, arteriovenous fistula, arteriovenous malformation, and other cerebral arteriopathies [17]. These causes can be revealed by angiographic evaluation. However, the reported incidence of angiographically occult spontaneous SAH (AOsSAH) is approximately 20% [3,10]. For investigating the source of AOsSAH, two or more successive angiographic follow-up evaluations are routinely performed. However, their detection rate is as low as 7–15% [11,12,28]. Spinal and brain magnetic resonance imaging (MRI) also has a very low detection rate [8,24,27]. Several vasculopathies such as deep venous system anomalies, vasculitis, and perforator aneurysm rupture are hypothesized as the possible causes of AOsSAH [4,18,25]. However, the definitive pathological cause is unclear.
According to the quantity and the location of hemorrhage, AOsSAH can be classified into three types : perimesencephalic, convexal, and diffuse [12,15,17,23]. The clinical course of AOsSAH is benign, especially in the convexal and perimesencephalic types; however, the diffuse type shows a clinical course resembling aneurysmal SAH. Approximately 20% diffuse AOsSAH cases exhibit a complicated course with delayed cerebral ischemia, hydrocephalus, and even rebleeding [3,13,15]. These features and the amount of SAH in diffuse AOsSAH suggest that there might be a hidden arteriopathy, which has not been unveiled.
Recently, three-dimensional (3D) high-resolution vessel wall MRI (HVM) is used to validate arterial wall pathologies such as dissection, aneurysmal wall stability, and the nature of plaque. The information of (pathologic) morphology of the arterial wall can be demonstrated on the 3D-HVM but not on the conventional angiography which only reflect the intraluminal blood flow [2,26]. This study aimed to reconsider the role of the HVM in investigating the arterial pathology of AOsSAH by illuminating the walls of the cerebral arteries.
MATERIALS AND METHODS
Ethical approval for this study was obtained from the Institutional Ethics Review Board of Guro Hospital, Korea University (approval number : 2020GR0299). The requirement for informed consent was waived because of the retrospective nature of the study. Data were extracted retrospectively from our prospective database, which includes surgical records, videos, and source angiography data of patients with SAH.
Patient enrolment
We retrospectively reviewed 251 patients who admitted to our hospital between January 2017 and December 2020 and were diagnosed with spontaneous SAH. Of them, 229 patients were diagnosed with definitive arteriopathy (aneurysm or other causes) on the initial angiographic evaluation. Twenty-two patients with negative findings on the initial angiographic evaluations, including computed tomography (CT) angiography and complete six-vessel cerebral angiography, were considered to have AOsSAH. Among them, three patients were excluded because they did not undergo 3D-HVM due to their poor conditions. Finally, 19 patients, who were diagnosed with AOsSAH in initial evaluations and underwent 3D-HVM during acute or the subacute phase, were enrolled (Fig. 1A).
Classification of SAH
Enrolled patients were classified as three groups according to the distribution and amount of their hemorrhages : convexal (n=2) or perimesencephalic (n=4), and diffuse type (n=13). Convexal SAH was defined as isolated hemorrhage in one or several adjacent sulci in the absence of blood at the basal cisterns, interhemispheric fissure, ventricle, or parenchyma [12]. According to the definition proposed by Rinkel et al. [23], perimesencephalic SAH was defined as a hemorrhage located immediately anterior to the midbrain with or without extension of blood into the ambient cistern or the Sylvian fissure and the absence of a clot in the anterior interhemispheric fissure or the intraventricular space. Hemorrhages that did not fulfil the aforementioned criteria and distributed diffusely in basal and Sylvian cisterns were classified as diffuse SAH [3]. The illustrative images of three types of AOsSAH are presented in Fig. 1B.
Clinical and radiologic data
Medical records of the enrolled patients were retrospectively reviewed including age, sex, hidden trauma histories, laboratory findings, clinical courses, and final modified Rankin Scale (mRS) scores. Every radiologic image was again reviewed. All patients underwent laboratory workups to reveal hidden malignancies, coagulopathies, and autoimmune diseases such as vasculitis. Brain and complete spinal MRIs were performed to determine other possible causes of SAH. Patients underwent contrast-enhanced 3D-HVM. Two certified neuroradiologists blinded to the clinical data independently evaluated the 3D-HVM findings. Abnormal arterial wall enhancement was defined as the presence of a moderate-to-strong arterial wall enhancement in the relevant location of the hematoma observed by comparing the pre-gadolinium and post-gadolinium T1-weighted images [20]. Disagreements between the two radiologists were resolved by consensus. All patients underwent one or more subsequent angiographic evaluation(s) regardless of the HVM findings. In patients with positive findings on HVM, special attention was paid to the enhancing lesion with high-resolution 3D reconstruction of rotational angiography images (Fig. 1B). The radiological and clinical data were analyzed retrospectively.
Protocol of 3D-HVM
The imaging protocol of 3D-HVM included the following : 1) a 3T scanner (Skyra; Siemens, Erlangen, Germany); 2) time of flight magnetic resonance angiography for the circle of Willis; 3) T2-weighted imaging and pre-gadolinium and postgadolinium enhanced T1-weighted sagittal imaging using isotropic 3D sampling perfection with application optimized contrast using different flip angle evolutions sequences with blood suppression for entire intracranial large arteries; and 4) multiplanar reconstruction for coronal or axial acquisition. The detailed imaging parameters are described in Table 1.
RESULTS
General demographics
Among the patients with sSAH (n=251), 22 patients were confirmed as AOsSAH in the initial angiographic evaluations of computed tomography angiography (CTA) and digital subtraction angiography (DSA) (8.76%). Among 19 enrolled patients, patients were classified as having convexal (n=2), perimesencephalic (n=4), and diffuse (n=13) AOsSAHs. Baseline characteristics of the enrolled patients were shown in Table 2. Female predominance (68.4%), mean age of 55-year-old, 26.5% of ventriculomegaly or hydrocephalus, and 5.3% of poor outcome (n=1; mRS score, 4) were noted.
Eighteen patients underwent 3D-HVM evaluation in the acute phase within 10 days of SAH onset during hospitalization, while one patient underwent 3D-HVM evaluation in the subacute phase (days 21 of SAH onset).
Convexal or perimesencephalic AOsSAH
Six patients were diagnosed with convexal or perimesencephalic AOsSAH (31.6%). Only the initial brain CT revealed the specific types of AOsSAH and every other radiologic image were noted as negative (CTA, initial DSA, 3D-HVM, spine and brain MRI, and repetitive DSAs). All patients with perimesencephalic and convexal AOsSAH showed excellent outcomes (mRS score, 0) with an uneventful course. The clinical courses of the patients were shown in Fig. 2A.
Diffuse AOsSAH
Thirteen patients were classified as diffuse-type AOsSAH (68.4%). They all underwent 3D-HVM and 10 patients showed positive findings of abnormal focal enhancement on the cerebral vessel wall (10/13, 76.9%). All patients underwent one or more additional follow-up angiographic evaluation(s) with high-resolution 3D reconstruction, the results of which were intensively interpreted with special attention to the location of the enhancement. Among 10 patients with HVM-positive enhancement, five patients showed angiographic abnormalities at the concordant locations of enhancement and hematoma sites on the initial CT (50%). The flowchart of the evaluations was shown in Fig. 2B. In terms of outcomes, two patients with diffuse AOsSAH had an eventful course with symptomatic vasospasm and hydrocephalus (mRS score, 1 and 4; 15.4%).
Tables 3 and 4 present the detailed information of HVM-positive patients (n=10). They all were in the diffuse-type AOsSAH and their initial Fisher’s grade was 3 or 4. Focal enhancement was noted in basilar artery (BA; n=6), internal carotid artery (n=2), or middle cerebral artery (n=2). Among 10 HVM-positive lesions, five were confirmed as pathologic in repetitive DSA (50%) : one definitive and one suspicious dissection (n=2), blood blister-like aneurysm (n=2), and small perforating artery aneurysm (n=1). The latter three patients eventually underwent endovascular treatment. And a dissection on middle cerebral artery trunk case was conservatively treated according to its benign clinical course and angiographic finding of no aneurysmal dilatation without progression to severe stenosis causing ischemia.
Illustrative cases
Two patients with strong enhancement of the medial wall of the supraclinoid internal carotid artery (non-branching site) were diagnosed with a blood blister-like aneurysm at the corresponding location. Their initial angiography did not reveal any vasculopathy and 3D-HVM findings lead to intense investigation on the second week follow-up angiography with 3D reconstruction and final diagnosis was made as ruptured blood blister-like aneurysm. These lesions were treated with overlapped Enterprise stents (Cordis Neurovascular, Miami, FL, USA) (Fig. 3).
Focal enhancement of the BA trunk was observed in six patients. Of them, one patient was found to have a blood blister-like or perforator aneurysm at the relevant spot of 3D-HVM enhancement on subsequent angiography. Weekly angiographic follow-up evaluations demonstrated increase in the size of the aneurysm, which was eventually treated with overlapped low-profile visualized intraluminal support (MicroVention-Terumo, Tustin, CA, USA) stent placement. Flow diverter stent was not considered according to the guidelines of Korean Insurance System (Fig. 4).
DISCUSSION
In this study, AOsSAH showed a high rate of focal abnormal arterial wall enhancement at the corresponding hematoma site on the 3D-HVM workup protocol in 10 of 19 patients (52.6%). In particular, in diffuse AOsSAH, strong enhancement of the relevant area of the cerebral artery was observed with a high incidence (76.9%). Subsequent angiographic evaluations revealed arteriopathies at the enhancement region on 3D-HVM in five patients (50% patients with positive 3D-HVM findings). Further, 3D-HVM was helpful in the detection of arteriopathies that were not visible on thorough angiographic evaluation in the early phase of the disease. 3D-HVM guided subsequent focused and intense evaluation for determining the causative arteriopathy.
The incidence of AOsSAH is approximately 20% in clinical practice [14]. Repeated angiography and MRIs of brain and spine are used to assess the vascular causes of AOsSAH. However, the yield rate of serial angiography is low (approximately 7–15%), and the detection rate of central nervous system MRI is even lower (approximately 4–8%) [9-11,27,28].
The etiology of perimesencephalic SAH has not been determined. A non-arterial source of hemorrhage has been proposed because of the sparse amount of hemorrhage and a relatively benign clinical course compared to aneurysmal SAH. Variants of the venous system such as the basal vein of Rosenthal have been suggested to be associated with this type of SAH [4,10,25].
Although the clinical outcome is generally favorable, 20% patients with AOsSAH exhibit poor clinical outcomes or events such as delayed cerebral ischemia, hydrocephalus, rebleeding, and neurological sequelae [1,5,12]. Large quantity of hemorrhage (Fisher grade >3) is associated with poor prognosis [13]. In particular, diffuse AOsSAH exhibits poor clinical outcomes [15]. Diffuse AOsSAH exhibits a clinical situation similar to aneurysmal SAH in terms of significant amount of hematoma with acute clinical demonstration, suggesting an arterial etiology for this type of AOsSAH. This prompts clinicians to perform repetitive angiographic evaluations to identify any evidence of arteriopathy. Angiography may yield false-negative results because of vascular thrombosis, mass effect by an adjacent hematoma, vasospasm, or technical inadequacy [12]. Therefore, repeated angiographic evaluation is considered mandatory. However, the detection rate of angiography for the contributing arteriopathy is low (approximately 15%) [11,12,28].
Even with unprecedented technological developments in angiography, it has critical limitations. Angiography cannot provide information beyond the arterial lumen. Recently, HVM techniques have been developed to subtract the blood flow signal from the vascular lumen. This process enables direct visualization of the vessel wall with enhanced differentiation among diverse cerebrovasculopathies [26]. Although interpretation of an HVM image is challenging and occasionally controversial, many reports have advocated its practicality. Recent studies have indicated that vulnerability of intracranial atheromatous plaque, presence of dissection, instability of unruptured aneurysms, and detection of ruptured aneurysms in cases of simultaneous multiple aneurysms can be validated using HVM [2,7,16,19,20,26]. Chung et al. [6] have published an interesting case series involving in vivo HVM investigation of hidden pathologic causes of various vertebral arterial diseases. Thus, vessel wall imaging has been extensively used as a complementary tool to luminal imaging modalities in cerebrovascular diseases. Our study also demonstrated the usefulness of vessel wall imaging in determining the possible cause of AOsSAH. In our study, 3D-HVM revealed a high proportion (76.9%) of lesions with abnormal enhancement in diffuse AOsSAH. Despite the small sample size, the results of consecutive patient data are encouraging and interesting. HVM clearly escalated the detection rate of vasculopathy in the subsequent evaluation by providing an opportunity to pay close attention to the specific region of the vessel wall. Ten patients were suspected to have a causative arteriopathy on 3D-HVM evaluation. Of them, contributing arteriopathy was confirmed in five patients (26.3% patients with all types of AOsSAH, 38.5% patients with diffuse AOsSAH, and 50% patients with positive findings on 3D-HVM) in subsequent angiography and three patients underwent definitive endovascular treatment. HVM did not change the treatment strategy in all cases, but it considerably contributed to the detection of vasculopathy in limited cases. Considering the rebleeding risk of up to 8.5% and a relatively large amount of hemorrhage in diffuse AOsSAH [15], the importance of information about the status of the arterial wall should not be overlooked. 3D-HVM provides physicians with a new insight—the arterial wall status—for the investigation of the usual suspects in AOsSAH.
Controversies regarding the interpretation of wall enhancement are anticipated. However, comparison of the images obtained in the T1, T2, and T1 enhancement protocols in our study enabled us to distinguish pathologic focal enhancement from enhancement that could be observed in adjacent hematoma or in atherosclerosis of the wall. Although we did not present the related data, three patients with diffuse AOsSAH and positive HVM findings who underwent conservative treatment were followed up with the same 3D-HVM protocol at 2 or 4 months after the onset of SAH; all demonstrated disappearance or waning of the previous enhanced lesions. This phenomenon in the chronic phase may imply that focal enhancement of relevant corresponding vessel wall in the acute or the subacute phase of AOsSAH could be considered a pathological change, which was either the cause or the result of SAH. The disappearance of the lesions also suggests that if they were the cause of the hemorrhage, they could heal spontaneously.
Recent studies have suggested that circumferential or strong focal enhancement of the aneurysm wall indicates an increased risk of unstable aneurysm [7,16]. Moreover, in the setting of SAH with multiple aneurysms, the culprit aneurysm has a tendency to exhibit enhancement circumferentially or focally at the rupture point [7,20]. Natori et al. [21] have demonstrated the usefulness of 3D-HVM in detection of intramural high-intensity signal in acute vertebrobasilar dissection in a prospectively designed study that compared 3D-HVM with conventional magnetic resonance angiography. These observations support the potential of our results in suggesting that focal wall enhancement indicates a high possibility of arterial cause in AOsSAH, especially in the diffuse type.
Park et al. [22] have demonstrated that the final angiographic diagnosis requires 3D angiographic evaluation. In our study, routine two-dimensional angiography could not demonstrate any abnormalities in the vessel wall, but the highly reconstructed 3D images revealed definitive arteriopathies in five patients with angiographic confirmation. Further, 3D-HVM played an important guiding role in thorough evaluation of the concordant lesions with repeated 3D angiography evaluation performed every week.
The study limitations include the small number of patients and the retrospective nature of the study. However, considering the consecutive nature of the patient data in our hospital, we believe that 3D-HVM in the acute phase of AOsSAH provided a valuable insight into the cause of hemorrhage.
CONCLUSION
3D-HVM in the acute phase of AOsSAH showed a high detection rate for abnormal focal wall enhancement in the cerebral arteries concordant with the responsible hematoma region, especially in cases of diffuse AOsSAH. Moreover, it provided resourceful guidance for further evaluation and subsequent treatment. The study findings may provide valuable evidence and insights for the research regarding the pathogenesis of AOsSAH.
XML Download